PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma‐initiating cell properties via DNA methyltransferase 3A. Issue 1 (16th July 2021)
- Record Type:
- Journal Article
- Title:
- PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma‐initiating cell properties via DNA methyltransferase 3A. Issue 1 (16th July 2021)
- Main Title:
- PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma‐initiating cell properties via DNA methyltransferase 3A
- Authors:
- Tanabe, Ryo
Miyazono, Kohei
Todo, Tomoki
Saito, Nobuhito
Iwata, Caname
Komuro, Akiyoshi
Sakai, Satoshi
Raja, Erna
Koinuma, Daizo
Morikawa, Masato
Westermark, Bengt
Heldin, Carl‐Henrik - Abstract:
- Abstract : Glioma‐initiating cells (GICs), a major source of glioblastoma recurrence, are characterized by the expression of neural stem cell markers and the ability to grow by forming nonadherent spheres under serum‐free conditions. Bone morphogenetic proteins (BMPs), members of the transforming growth factor‐β family, induce differentiation of GICs and suppress their tumorigenicity. However, the mechanisms underlying the BMP‐induced loss of GIC stemness have not been fully elucidated. Here, we show that paired related homeobox 1 (PRRX1) induced by BMPs decreases the CD133‐positive GIC population and inhibits tumorigenic activity of GICs in vivo . Of the two splice isoforms of PRRX1, the longer isoform, pmx‐1b, but not the shorter isoform, pmx‐1a, induces GIC differentiation. Upon BMP stimulation, pmx‐1b interacts with the DNA methyltransferase DNMT3A and induces promoter methylation of the PROM1 gene encoding CD133. Silencing DNMT3A maintains PROM1 expression and increases the CD133‐positive GIC population. Thus, pmx‐1b promotes loss of stem cell‐like properties of GICs through region‐specific epigenetic regulation of CD133 expression by recruiting DNMT3A, which is associated with decreased tumorigenicity of GICs. Abstract : BMPs induce differentiation and apoptosis of glioma‐initiating cells (GICs). Here, we identified PRRX1 as a target of BMPs in GICs. Of the two splice isoforms, only pmx‐1b induced GIC differentiation. Through interaction with DNMT3A, pmx‐1b induced theAbstract : Glioma‐initiating cells (GICs), a major source of glioblastoma recurrence, are characterized by the expression of neural stem cell markers and the ability to grow by forming nonadherent spheres under serum‐free conditions. Bone morphogenetic proteins (BMPs), members of the transforming growth factor‐β family, induce differentiation of GICs and suppress their tumorigenicity. However, the mechanisms underlying the BMP‐induced loss of GIC stemness have not been fully elucidated. Here, we show that paired related homeobox 1 (PRRX1) induced by BMPs decreases the CD133‐positive GIC population and inhibits tumorigenic activity of GICs in vivo . Of the two splice isoforms of PRRX1, the longer isoform, pmx‐1b, but not the shorter isoform, pmx‐1a, induces GIC differentiation. Upon BMP stimulation, pmx‐1b interacts with the DNA methyltransferase DNMT3A and induces promoter methylation of the PROM1 gene encoding CD133. Silencing DNMT3A maintains PROM1 expression and increases the CD133‐positive GIC population. Thus, pmx‐1b promotes loss of stem cell‐like properties of GICs through region‐specific epigenetic regulation of CD133 expression by recruiting DNMT3A, which is associated with decreased tumorigenicity of GICs. Abstract : BMPs induce differentiation and apoptosis of glioma‐initiating cells (GICs). Here, we identified PRRX1 as a target of BMPs in GICs. Of the two splice isoforms, only pmx‐1b induced GIC differentiation. Through interaction with DNMT3A, pmx‐1b induced the methylation of the PROM1 gene promoter and suppressed the CD133 + GIC population. Thus, site‐specific epigenetic regulation plays a critical role in the differentiation of GICs. … (more)
- Is Part Of:
- Molecular oncology. Volume 16:Issue 1(2022)
- Journal:
- Molecular oncology
- Issue:
- Volume 16:Issue 1(2022)
- Issue Display:
- Volume 16, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 16
- Issue:
- 1
- Issue Sort Value:
- 2022-0016-0001-0000
- Page Start:
- 269
- Page End:
- 288
- Publication Date:
- 2021-07-16
- Subjects:
- BMP -- cancer‐initiating cell -- CD133 -- DNA methyltransferase -- glioblastoma -- PRRX1
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.13051 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20434.xml